Insight Molecular Diagnostics Goodwill and Intangible Assets 2014-2025 | IMDX

Insight Molecular Diagnostics goodwill and intangible assets from 2014 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Insight Molecular Diagnostics Goodwill and Intangible Assets 2014-2025 | IMDX

Insight Molecular Diagnostics goodwill and intangible assets from 2014 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$47.5B
Tempus AI (TEM)$14B
Doximity (DOCS)$12.7B
Hims & Hers Health (HIMS)$10.1B
IRhythm Technologies (IRTC)$5.4B
Hinge Health (HNGE)$4.5B
Inspire Medical Systems (INSP)$2.8B
Privia Health (PRVA)$2.7B
Heartflow (HTFL)$2.4B
Enovis (ENOV)$1.8B
10x Genomics (TXG)$1.8B
Phreesia (PHR)$1.8B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.5B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.4B
Claritev (CTEV)$1.2B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$666M
Zepp Health (ZEPP)$580M
Veradigm (MDRX)$525M
Standard BioTools (LAB)$485M
Talkspace (TALK)$469M
Butterfly Network (BFLY)$383M
Carlsmed (CARL)$346M
TruBridge (TBRG)$307M
Outset Medical (OM)$252M
SOPHiA GENETICS SA (SOPH)$244M
Health Catalyst (HCAT)$231M
Nyxoah SA (NYXH)$219M